 "Bharat Biotech's Covaxin effective against Covid-19 UK strain: ICMR")
Covaxin has similar efficacy and generates immune response against both the UK coronavirus strain and the one found in India, according to a paper published by scientists from the Indian Council of Medical Research (ICMR) and Bharat Biotech.
The scientists performed a “plaque reduction neutralisation test”, which measures the concentration of antibodies of a virus, on 26 recipients of Covaxin against the UK-variant and the heterologous strain. Sera — the fluid part of the blood called serum that also contains antibodies generated against any pathogen — collected from these 26 people was used to see if it worked against the UK
